Argentina's ANMAT revokes 25 drug authorizations over expired registrations

Argentina's health regulator ANMAT canceled marketing authorizations for 25 medicines across 15 companies after detecting expired registration certificates with no renewal initiated. The move disrupts supply of these products domestically, though the specific drugs and affected firms are not named. This signals stricter regulatory enforcement that could create short-term shortages and compliance pressure on manufacturers.